FONAR Stock (NASDAQ:FONR)


RevenueOwnershipFinancialsChart

Previous Close

$19.09

52W Range

$13.62 - $19.16

50D Avg

$18.82

200D Avg

$17.10

Market Cap

$117.76M

Avg Vol (3M)

$80.43K

Beta

1.02

Div Yield

-

FONR Company Profile


FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

533

IPO Date

Oct 29, 1981

Website

FONR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 25
Total$104.35M

Fiscal year ends in Jun 25 | Currency in USD

FONR Financial Summary


Jun 25Jun 24Jun 23
Revenue$104.35M$102.88M$98.65M
Operating Income$11.60M$16.54M$14.79M
Net Income$8.33M$10.57M$9.38M
EBITDA$16.30M$28.25M$24.61M
Basic EPS$1.21$1.56$1.35
Diluted EPS$1.21$1.53$1.32

Fiscal year ends in Jun 25 | Currency in USD

Peer Comparison


TickerCompany
QIPTQuipt Home Medical Corp.
LUNGPulmonx Corporation
ARTVArtiva Biotherapeutics, Inc.
NSPRInspireMD, Inc.
IFRXInflaRx N.V.
APYXApyx Medical Corporation
RCELAvita Medical Inc.
VANIVivani Medical, Inc.
HYPRHyperfine, Inc.